Results 181 to 190 of about 75,915 (258)

Lipid Dependence of CYP3A4 Activity in Nanodiscs. [PDF]

open access: yesBiology (Basel)
Denisov IG, Grinkova YV, Sligar SG.
europepmc   +1 more source

Transforming Treatment: The Impact of Bariatric Surgery on Oral Drug Absorption

open access: yesObesity Reviews, Volume 27, Issue 4, April 2026.
ABSTRACT Obesity represents a significant threat to global public health, with an estimated 16% of adults worldwide (2022) being classified as people with obesity, with a body mass index of 30 or more. Bariatric surgery is regarded as the most effective treatment option for people with obesity, with the three main types of bariatric surgery being ...
Danielle Wigg   +3 more
wiley   +1 more source

Evaluation of Drug-Drug Interaction Potential Between the Oral Antibiotic Zoliflodacin and the CYP3A4 Inhibitor Itraconazole: A Phase 1 Study in Healthy Participants. [PDF]

open access: yesClin Transl Sci
Luckey A   +10 more
europepmc   +1 more source

Risks of thrombosis and hemorrhage in concurrent use of anticoagulants and potential interacting prostate cancer agents

open access: yesCancer, Volume 132, Issue 6, 15 March 2026.
Abstract Background Pharmacokinetic studies suggest that specific prostate cancer therapies may alter the metabolism of direct oral anticoagulants (DOACs), leading to elevated risks of thrombosis or bleeding. Methods To assess the risk of thrombosis or bleeding, population‐based, retrospective, parallel analyses were conducted in Ontario and Alberta ...
Tzu‐Fei Wang   +10 more
wiley   +1 more source

A phase 1 study of berzosertib (M6620, VX‐970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950)

open access: yesCancer, Volume 132, Issue 6, 15 March 2026.
ABSTRACT Background Ataxia telangiectasia Rad3‐related (ATR) protein kinase regulates DNA damage response and is essential for tumor cell survival. Preclinically, ATR inhibition can sensitize tumor cells to radiation and chemotherapy. The authors conducted a phase 1 trial of berzosertib, a selective ATR inhibitor, in combination with definitive ...
Aarti Bhatia   +26 more
wiley   +1 more source

Influence of CYP2D6 Genotypes and Phenotypes on the Plasma Levels and Clinical Response to Aripiprazole. [PDF]

open access: yesSchizophr Bull
Gras C   +14 more
europepmc   +1 more source

Role of CYP3A4 in kinase inhibitor metabolism and assessment of CYP3A4 activity

open access: yesTranslational Cancer Research, 2017
Gerd Mikus, Kathrin Isabelle Foerster
openaire   +1 more source

Modulation of Tau Protein Neurotoxic Hallmarks by Novel σ1R Agonists/HDAC Inhibitor Dual‐Acting Compounds

open access: yesChemMedChem, Volume 21, Issue 5, 13 March 2026.
This study explores the development of dual‐acting compounds combining σ1R agonists and histone deacetylase inhibitors (HDACi). Key findings include compound 2d and 3a's high affinity for σ1R and favorable pharmacokinetic profile and an in vivo determined σ1R agonist profile by reversing the effect of the σ1R antagonist BD‐1063.
Antonino N. Fallica   +16 more
wiley   +1 more source

Pharmacogenetics of CYP3A5 in Pediatric Patients With Eosinophilic Esophagitis. [PDF]

open access: yesClin Transl Sci
Noel-MacDonnell J   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy